oasis 1 trial oral semaglutide 50 mg obesity nejm 2023 of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Oral vs. Injectable Semaglutide: Effectiveness
Description
Read source Wharton, S., et al
[DOI] [PubMed] [Google Scholar] 172.Nie Y, Nakashima M, Brubaker PL, Li QL, Perfetti R, Jansen E, Zambre Y, Pipeleers D, Friedman TC
Appetite-regulation systems
Psychological issues Its not surprising that those who start these medications may be anxious about stopping them
These unregulated versions may carry safety risks and impurities, and reduce their effectiveness
N.BoydK
